Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: Outcomes from the FAME-2 trial

Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: Outcomes from the FAME-2 trial

Background-There is no drug therapy for abdominal aortic aneurysm (AAA). FAME-2 (Fenofibrate in the Management of Abdominal Aortic Aneurysm 2) was a placebo-controlled randomized trial designed to assess whether administration of 145 mg of fenofibrate/d for 24 weeks favorably modified circulating ma...

Full description

Bibliographic Details
Main Authors: Pinchbeck, J., Moxon, J., Rowbotham, S., Bourke, M., Lazzaroni, S., Morton, S., Matthews, E., Hendy, K., Jones, R., Bourke, B., Jaeggi, R., Favot, D., Quigley, F., Jenkins, J., Reid, Christopher, Velu, R., Golledge, J.
Format: Journal Article
Published: Wiley-Blackwell 2018
Online Access:http://hdl.handle.net/20.500.11937/74767

Internet

http://hdl.handle.net/20.500.11937/74767

Similar Items